Filing Details
- Accession Number:
- 0001567619-21-012251
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-16 20:38:31
- Reporting Period:
- 2021-06-15
- Accepted Time:
- 2021-06-16 20:38:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1409269 | Venus Concept Inc. | VERO | Surgical & Medical Instruments & Apparatus (3841) | 061681204 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1789724 | Domenic Penna Della | C/O Venus Concept Inc. 235 York Boulevard, Suite 900 Toronto A6 M2J 4Y8 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2021-06-15 | 15,000 | $2.43 | 41,663 | No | 4 | P | Direct | |
| Common Shares | Acquisiton | 2021-06-15 | 25,000 | $2.39 | 66,663 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.385 to $2.43, inclusive. The reporting person undertakes to provide to Venus Concept Inc., any security holder of Venus Concept Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.35 to $2.41, inclusive. The reporting person undertakes to provide to Venus Concept Inc., any security holder of Venus Concept Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above
Billionaire Hedge Funds
